As a downstream factor of NF-κB signalling, the newly produced GADD45β is expressed at a high level in the MM cells and interacts with MKK7 in the JNK pathway, promoting the survival of MM cells [4,26,27] (detailed information is included in part B). The gene discussed is NFKB1; the disease is Miyoshi myopathy.